LONDON (Reuters) – AstraZeneca’s board will be reviewing a sweetened takeover offer from Pfizer but the company has no further comment at this stage, a spokeswoman for the British drugmaker said on Friday. Earlier the U.S. drugmaker revealed it had raised its offer for the…
Source:AstraZeneca says board will review Pfizer offer
No comments:
Post a Comment